The Manufacturers Life Insurance Company bought a new stake in eMagin Co. (NYSEAMERICAN:EMAN – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,232,687 shares of the semiconductor company’s stock, valued at approximately $65,258,000. The Manufacturers Life Insurance Company owned about 1.48% of eMagin at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of EMAN. Allianz Asset Management GmbH bought a new stake in eMagin during the 2nd quarter worth approximately $322,000. Amundi bought a new position in eMagin in the 2nd quarter valued at $12,718,000. TD Waterhouse Canada Inc. bought a new position in eMagin in the 2nd quarter valued at $9,591,000. Mufg Securities Canada LTD. acquired a new position in eMagin in the second quarter worth $896,000. Finally, Royal London Asset Management Ltd. acquired a new position in eMagin in the second quarter worth $744,000. 33.36% of the stock is owned by institutional investors and hedge funds.
eMagin Price Performance
Shares of EMAN stock opened at $2.07 on Friday. eMagin Co. has a 52 week low of $0.69 and a 52 week high of $2.49. The stock has a market capitalization of $172.20 million, a PE ratio of -13.80 and a beta of 2.03. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.16 and a current ratio of 2.06. The stock’s fifty day moving average is $2.07 and its 200-day moving average is $2.07.
eMagin Profile
eMagin Corporation, headquartered in Hopewell Junction, New York, is a technology company specializing in the design, development and manufacture of high-resolution organic light-emitting diode (OLED) microdisplays. Since its founding in 1996, eMagin has focused on delivering advanced active-matrix OLED (AMOLED) microdisplay solutions for near-to-eye applications, including virtual reality (VR), augmented reality (AR), military and industrial head-mounted systems, as well as medical imaging devices.
The company’s core product portfolio features monochrome and full-color OLED microdisplays that offer high contrast ratios, wide color gamut and low power consumption in a compact form factor.
Further Reading
- Five stocks we like better than eMagin
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
